Triple therapy prevention of Recurrent Intracerebral Disease Events Trial
Lead PI: Prof Craig Anderson & Prof Clara Chow
No. of Patients Currently Recruited: 473 No. of Patients Required: 4200
TRIDENT is an international, multi-centre, randomised control trial aiming to determine the effect of more intensive blood pressure control, utilising a low-dose combination of blood pressure medications, to prevent recurrent stroke in patients who have had an intracerebral haemorrhage (ICH).
Trial URL: https://www.tridentstudy.org/
ClinicalTrials.gov Identifier: NCT02699645